CNSX:PWRPharmadrug Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Pharmadrug Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.52 +0.04 (+8.33 %) (As of 07/3/2020 04:00 PM ET) Add Compare Share Today's Range$0.50Now: $0.52▼$0.5250-Day Range N/A52-Week Range N/AVolume218,670 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesOptions Chain Captiva Verde Land Corp. operates as a health and wellness company. Its assets include sustainable real estate communities in California; outdoor organic cannabis cultivation in Canada; premium infused products and consumer retail partnerships across North America; and medical cannabis license product distribution in Mexico. It primarily invests in assets that contain green residential communities, disruptive manufacturing facilities, organic food production, and pharmaceutical products. The company was formerly known as Just Baseball Limited and changed its name to Captiva Verde Land Corp. in March 2017. Captiva Verde Land Corp. was incorporated in 2015 and is based in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingPharmadrug has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.86, Pharmadrug has a potential upside of 65.4% from its current price of $0.52.Amount of Analyst CoveragePharmadrug has only been the subject of 1 research reports in the past 90 days. Previous Next 0.0 Community Rank Outperform VotesPharmadrug has received 1 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPharmadrug has received 0 “underperform” votes. (Add your “underperform” vote.)MarketBeat's community ratings are surveys of what our community members think about Pharmadrug and other stocks. Vote “Outperform” if you believe PWR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PWR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPharmadrug does not currently pay a dividend.Dividend GrowthPharmadrug does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Pharmadrug insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.70 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Real Estate Services Sub-IndustryN/A SectorReal Estate Current SymbolCNSX:PWR Previous Symbol CUSIPN/A CIKN/A Webwww.captiva-verde.com PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable TSXV:PWR Rates by TradingView Receive PWR News and Ratings via Email Sign-up to receive the latest news and ratings for PWR and its competitors with MarketBeat's FREE daily newsletter. Pharmadrug (CNSX:PWR) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of Pharmadrug? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pharmadrug in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Pharmadrug. What price target have analysts set for PWR? 1 brokers have issued 1-year target prices for Pharmadrug's stock. Their forecasts range from $0.86 to $0.86. On average, they expect Pharmadrug's share price to reach $0.86 in the next year. This suggests a possible upside of 65.4% from the stock's current price. View analysts' price targets for Pharmadrug. Has Pharmadrug been receiving favorable news coverage? Media headlines about PWR stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pharmadrug earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term. View the latest news about Pharmadrug. Who are some of Pharmadrug's key competitors? Some companies that are related to Pharmadrug include Aroundtown (AANNF), Crop Infrastructure (CRXPF), Duo World (TNHDF), F&C Commercial Property Trust (FCPT), First Capital Realty (FCRGF), FutureLand (FUTL), Gazit Globe (GZT), Grand City Properties (GYC), Inpex (VNNVF), Metalo Manufacturing (MMI), Mitsubishi Estate (SURDF), New Age Brands (NWGFF), New Age Brands (NF), Prime Global Capital Group (PGCG) and REAC Group (REAC). View all competitors. Who are Pharmadrug's key executives? Pharmadrug's management team includes the following people: Mr. Jeffrey J. Ciachurski, CEO & Director (Age 60)Mr. Anthony Bob Balic, Chief Financial Officer (Age 38, Pay $60k) What is Pharmadrug's stock symbol? Pharmadrug trades on the CNSX under the ticker symbol "PWR." How do I buy shares of Pharmadrug? Shares of PWR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Pharmadrug's stock price today? One share of PWR stock can currently be purchased for approximately $0.52. What is Pharmadrug's official website? The official website for Pharmadrug is www.captiva-verde.com. This page was last updated on 7/5/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
